Abiopharma

New Form 8-K - Keros Therapeutics, Inc. Filed: 2025-06-09 AccNo: 0001664710-25-000057 Size: 232 KB Item 5.07: Submission of Matters to a Vote of Security Holders Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits